The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of treatment with panitumumab, cetuximab, and bevacizumab among mCRC patients with wild-type RAS or BRAF treated at community cancer centers in the United States.
 
Tamer Garawin
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Kimberly Lowe
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Michael Anthony Kelsh
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Gerry C. Bohac
Employment - Amgen
Stock and Other Ownership Interests - Amgen